Clinical determinants of SARS-CoV-2 vaccine response in adults with cancer

E. Segelov, A. Body, L. Lal, H. Abdulla,S. Turville, Z. Naing,S. Opat, M. Leahy, J. R. Balendra,N. Hamad,R. Mccuaig,S. Rao,K. Lineburg, C. Smith,C. R. MacIntyre,V. Milch,L. Busija,E. S. Ahern

ANNALS OF ONCOLOGY（2022）

引用 0|浏览2

暂无评分

摘要

Adults with cancer are susceptible to severe SARS-CoV-2 disease. Emerging data show initial response to COVID-19 vaccination in most patients (pts) with solid cancer, many with haematological (haem) cancer remain vulnerable. Data beyond initial response and regarding effect of booster doses are lacking.

查看译文

关键词

1611p clinical determinants,cancer,sars-cov

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要